ELI LILLY & Co — Director's Dealing 2023

Feb 14, 2023

SEC Form 4 — Statement of Changes in Beneficial Ownership

Issuer: ELI LILLY & Co (LLY)
CIK: 0000059478
Period of Report: 2023-02-10

Reporting Person: Ricks David A (Director, President, Chair, and CEO)

Non-Derivative Transactions

Date	Security	Code	Shares	Price	A/D	Holdings After	Ownership
2023-02-08	Common Stock	G	4200	—	Disposed	387543	Direct
2023-02-10	Common Stock	A	56208	$345.12	Acquired	443751	Direct

Derivative Transactions

Date	Security	Exercise Price	Code	Shares	A/D	Expiration	Underlying	Ownership
2023-02-10	Restricted Stock Unit	$	A	29611	Acquired	2024-02-01	Common Stock (29611.0)	Direct

Holdings (Non-Derivative)

Security	Shares	Ownership
Common Stock	67700	Indirect
Common Stock	70000	Indirect
Common Stock	7171	Indirect

Footnotes

F1: On February 8, 2023, the Reporting Person transferred 4,200 shares of Eli Lilly and Company common stock to a spousal lifetime access trust, of which the Reporting Person's wife is the trustee and the Reporting Person's wife and children are beneficiaries. The Reporting Person disclaims beneficial ownership of the reported securities except to the extent of his pecuniary interest therein and this report shall not be deemed an admission that the Reporting Person is the beneficial owner of the reported securities for purposes of Section 16 or for any other purpose.

F2: The reporting person disclaims beneficial ownership of the reported securities except to the extent of his pecuniary interest therein.

F3: Each restricted stock unit represents a contingent right to receive one share of Eli Lilly and Company common stock.